Article

MIRE vs. Placebo

Fed Pract. 2006 April;23(4):52
PDF Download

 

Recommended Reading

Inhaled Insulin vs. Dual Oral Therapy
Federal Practitioner
Thwarting Diabetic Foot Ulcers
Federal Practitioner
Rosiglitazone to Prevent Restenosis
Federal Practitioner
Surprising Findings on Diabetic Neuropathy
Federal Practitioner
Effects of Statins in Type 2 Diabetes
Federal Practitioner
Post-PCI Fluvastatin for Diabetics
Federal Practitioner
New Evidence on Link Between Agent Orange and Diabetes
Federal Practitioner
Effects of Stress on Glucose Levels
Federal Practitioner
How Valuable Are Short-Acting Insulin Analogs?
Federal Practitioner
ACE Inhibitors and ARBs for Diabetes Prevention
Federal Practitioner